←
APS_ACTION212 posts
APS_ACTION avatar

APS_ACTION

@APS_ACTION

APS ACTION is a network of internationally renown physicians & scientists working to find a cure for Antiphospholipid Syndrome or #APS

◷ Joined March 2013▧ 57 Photos and videos
APS_ACTION avatar
APS_ACTION@APS_ACTION·12 Sep 2025

@APS_ACTION Scientific Session and Poster Presentations During #ICAPA25 (18th International Congress on Antiphospholipid Antibodies, Kyoto, Japan). Thank you to all the presenters and session participants.

Post attachmentPost attachment
APS_ACTION avatar
APS_ACTION@APS_ACTION·12 Sep 2025

Congratulations to 2025 APSACTION Silvia Pierangeli Young Scholar Award (in collaboration with APS Foundation of America) Recipients: Alice Barinotti, Zeynep Erton, Alex Luta, Liala Moschetti, Andrew Song. During #ICAPA25, Alice and Zeynep received their certificates in person.

Post attachmentPost attachment
APS_ACTION avatar
APS_ACTION@APS_ACTION·4 Feb 2025

Predictors of Mortality in Antiphospholipid Antibody Positive Patients: Prospective Results from APS ACTION. pubmed.ncbi.nlm.nih.gov/3989…

APS Support UK avatar
⟳ APS_ACTION retweeted
APS Support UK@APSsupportUK·20 Jan 2025

Survey Reveals 60% Satisfaction with DIAPS but Highlights Need for Improvements: cutt.ly/ge3C9xa4 @APS_ACTION @DorukErkanMD

APS_ACTION avatar
APS_ACTION@APS_ACTION·20 Dec 2024

2023 American College of Rheumatology/European League Against Rheumatism antiphospholipid syndrome classification c… pubmed.ncbi.nlm.nih.gov/3939…

APS_ACTION avatar
APS_ACTION@APS_ACTION·15 Dec 2024

Thrombosis recurrence and major bleeding in non-anticoagulated thrombotic antiphospholipid syndrome patients: Prosp… pubmed.ncbi.nlm.nih.gov/3818…

APS_ACTION avatar
APS_ACTION@APS_ACTION·13 Dec 2024

ANA-positive versus ANA-negative Antiphospholipid Antibody-positive Patients: Results from the APS ACTION Clinical … pubmed.ncbi.nlm.nih.gov/3942…

APS_ACTION avatar
APS_ACTION@APS_ACTION·13 Dec 2024

Damage Index for Antiphospholipid Syndrome (DIAPS): An Antiphospholipid Syndrome Alliance for Clinical Trials and I… pubmed.ncbi.nlm.nih.gov/3966…

APS_ACTION avatar
APS_ACTION@APS_ACTION·9 Jan 2024

Our most recent publication on thrombosis recurrence and major bleeding risk in non-anticoagulated thrombotic antiphospholipid syndrome patients. We want to thank all APS ACTION members for their contributions. pubmed.ncbi.nlm.nih.gov/3818…

RPTH avatar
⟳ APS_ACTION retweeted
RPTH@RPTHjournal·8 Dec 2023

ICYMI: In this #RPTH Commentary @crowthrm and @DorukErkanMD discuss the new ACR/EULAR 2023 #Antiphospholipid Syndrome classification and how it may be applied across different clinical scenarios! Read here➡️: rpthjournal.org/article/S247…

Doruk Erkan avatar
⟳ APS_ACTION retweeted
Doruk Erkan@DorukErkanMD·1 Dec 2023

Antiphospholipid Syndrome Diagnosis versus Classification. What is the Difference? The answer is in this recently updated @HSpecialSurgery Top 10 Series Patient Web Article hss.edu/conditions_top-ten-p…